Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized placebo-controlled MMF immunomonitoring study in healthy volunteers
NL-OMON48101Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in organ allograft rejection comparing Mycophenolate mofetil with Placebo (2 arms). Primary endpoints: Tolerability and safety, Plasma mycophenolic acid levels and 5 more. Started May 2019; status: active, not recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
organ allograft rejection
Beyond the preview
Go deeper on NL-OMON48101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48101.